SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-06-006831
Filing Date
2006-11-09
Accepted
2006-11-09 15:56:42
Documents
7
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b62605ape10vq.htm 10-Q 433704
2 EX-10.1 COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN THE REGISTRANT AND BI b62605apexv10w1.txt EX-10.1 192612
3 EX-10.2 LETTER AGREEMENT BY AND BETWEEN THE REGISTRANT AND VINCENT J. MILES EFFE b62605apexv10w2.txt EX-10.2 24865
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO b62605apexv31w1.htm EX-31.1 8812
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO b62605apexv31w2.htm EX-31.2 8797
6 EX-32.1 SECTION 906 CERTIFICATION OF CEO b62605apexv32w1.htm EX-32.1 4119
7 EX-32.2 SECTION 906 CERTIFICATION OF CFO b62605apexv32w2.htm EX-32.2 3876
  Complete submission text file 0000950135-06-006831.txt   678263
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 061202103
SIC: 2834 Pharmaceutical Preparations